Pericarditis resident survival guide: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
* [[Aortic dissection]]
* [[Aortic dissection]]
* [[Myocardial Infarction]]
* [[Myocardial infarction]]
* [[Uremia]]
* [[Uremia]]


Line 21: Line 21:


==Management==
==Management==
The following is an algorithm depicting the management of [[acute pericarditis]] in adults.<ref name="pmid15120056">{{cite journal| author=Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y et al.| title=Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. | journal=Eur Heart J | year= 2004 | volume= 25 | issue= 7 | pages= 587-610 | pmid=15120056 | doi=10.1016/j.ehj.2004.02.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15120056  }} </ref><ref name="pmid23998693">{{cite journal| author=Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B et al.| title=American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. | journal=J Am Soc Echocardiogr | year= 2013 | volume= 26 | issue= 9 | pages= 965-1012.e15 | pmid=23998693 | doi=10.1016/j.echo.2013.06.023 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23998693  }} </ref><ref name="pmid20177006">{{cite journal| author=Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y| title=Controversial issues in the management of pericardial diseases. | journal=Circulation | year= 2010 | volume= 121 | issue= 7 | pages= 916-28 | pmid=20177006 | doi=10.1161/CIRCULATIONAHA.108.844753 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20177006  }} </ref>
{{Family tree/start}}
{{Family tree/start}}
{{familytree  | | | | | | | | | | C01 | | | | | | | | | | | | | | C01=<div style="float: left; text-align: left; padding:1em;">'''Characterize the Clinical, EKG and imaging findings'''<br>
❑ Characteristic [[chest pain]]  <br>
:❑ Sharp and pleuritic that is improved by sitting up and leaning forward
❑ [[Pericardial friction rub]] <BR>
:❑ High pitched, scratchy sound at the left sternal border best heard with diaphragm of the stethoscope
:❑ Heard during [[atrial systole]], [[ventricular systole]] and rapid ventricular filling during early [[diastole]]
❑ Suggestive EKG changes <br>
:❑ Diffuse ST elevation with reciprocal ST depression in leads aVR and V1
❑ Suggestive [[echocardiography]] changes <br>
:❑ New or worsening [[pericardial effusion]]  <br>
</div>}}
{{familytree  | | | | | | | | | | |!| | | | | | | | | | | | |}}
{{familytree  | | | | | | | | | | C01 | | | | | | | | | | | | | | C01=Consider a possible diagnosis of [[acute pericarditis]]}}
{{familytree  | | | | | | | | | | |!| | | | | | | | | | | | |}}
{{familytree  | | | | | | | | | | A01 | | | | | | | | | | | | | | A01= <div style="float: left; text-align: left; width: 30em; padding:1em;"> '''Characterize the symptoms:'''<br>
{{familytree  | | | | | | | | | | A01 | | | | | | | | | | | | | | A01= <div style="float: left; text-align: left; width: 30em; padding:1em;"> '''Characterize the symptoms:'''<br>
'''Symptoms suggestive of [[pericarditis]]:'''<br>
'''Symptoms suggestive of [[pericarditis]]:'''<br>
Line 27: Line 43:
:❑ Sudden onset
:❑ Sudden onset
:❑ Sharp or dull, aching and pressure like
:❑ Sharp or dull, aching and pressure like
:❑ Pleuritic (exacerbated by [[inspiration]] and coughing)
:❑ Pleuritic (exacerbated by [[inspiration]] and [[coughing]])
:❑ Retrosternal or radiation to neck, arms, [[trapezius]] muscle ridges
:❑ Retrosternal or radiation to neck, arms, [[trapezius]] muscle ridges
:❑ Affected by position (improved by sitting up and leaning forward)<br>
:❑ Affected by position (improved by sitting up and leaning forward)<br>
Line 57: Line 73:
:❑ [[Tuberculosis]]
:❑ [[Tuberculosis]]
:❑ [[HIV]]
:❑ [[HIV]]
:❑ Travel history<br>
:❑ Travel history
<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed">
::❑ Travel to  Central or South America ([[Chagas disease]])
::❑ Travel to  Central Asia or South Africa ([[Tuberculosis]])
::❑ Travel to  North and Central America (Ohio and Mississippi River valleys) ([[Histoplasmosis]])
::❑ Travel to  North America ([[Blastomycosis]])
</div></div><br>
❑ [[Pericarditis causes#Causes by Organ System|Medications]]<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed">
❑ [[Pericarditis causes#Causes by Organ System|Medications]]<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed">
:❑ [[5-Fluorouracil]]
:❑ [[5-Fluorouracil]]
:❑ [[Amiodarone]]
:❑ [[Amiodarone]]
:❑ [[Anticoagulants]]  
:❑ [[Anticoagulants]]
:❑ [[Cyclosporine]]
:❑ [[Cyclosporine]]
:❑ [[Cyclyphosphamide]]
:❑ [[Cyclyphosphamide]]
Line 83: Line 105:
:❑ [[Cardiac surgery]]
:❑ [[Cardiac surgery]]
:❑ [[Radiation exposure]]
:❑ [[Radiation exposure]]
:❑ Post myocardial infarction
:❑ [[Dressler's syndrome]]
:❑ [[Postpericardiotomy syndrome]]
:❑ Trauma history <br>
:❑ Trauma history <br>
</div>}}
</div>}}
Line 95: Line 118:
:❑ [[Blood pressure]]
:❑ [[Blood pressure]]
::❑ Normal (usual)
::❑ Normal (usual)
::❑ [[Hypotension]] (in cardiac tamponade)
::❑ [[Hypotension]] (in [[cardiac tamponade]])
:❑ [[Temperature]]
:❑ [[Temperature]]
::❑ [[Fever]] less than 39°C or 102.2°F  
::❑ [[Fever]] less than 39°C or 102.2°F
::❑ [[Hypothermic]] (in elderly and [[renal failure]])
::❑ [[Hypothermic]] (in elderly and [[renal failure]])
:❑ [[Respiratory rate]]
:❑ [[Respiratory rate]]
::❑ [[Tachypnea]]
::❑ [[Tachypnea]]
❑ Cardiovascular: <br>
❑ Cardiovascular: <br>
:❑ Heart sounds  
:❑ Heart sounds
::❑ Normal (usual)
::❑ Normal (usual)
::❑ Distant and muffled (in cardiac tamponade)
::❑ Distant and muffled (in [[cardiac tamponade]])
:❑ [[Pericardial friction rub]]
:❑ [[Pericardial friction rub]]
::❑ High pitched, scratchy or squeaky sound  
::❑ High pitched, scratchy or squeaky sound
::❑ Best heard at the left sternal border  
::❑ Best heard at the left sternal border
::❑ Best heard with the diaphragm of the stethoscope
::❑ Best heard with the diaphragm of the stethoscope
::❑ Vary in intensity overtime and need reapeated examinations  
::❑ Vary in intensity overtime and need reapeated examinations
(https://www.youtube.com/watch?v=fI4XXFRotNE)
{{#ev:youtube|watch?v=EUCp_3_vwtw}}
:❑ [[Jugular venous pulse]]
:❑ [[Jugular venous pulse]]
::❑ Elevated (in tamponade and [[constrictive pericarditis]]) <br>
::❑ Elevated (in [[cardiac tamponade]] and [[constrictive pericarditis]]) <br>
::❑ [[Kussmaul sign]] (in constrictive pericarditis) <br>
::❑ [[Kussmaul sign]] (in [[constrictive pericarditis]]) <br>
:❑ Any [[murmer]]<br>
:❑ Any [[murmur]]<br>
:❑ Percuss cardiac dullness<br>
:❑ Percuss cardiac dullness<br>
::❑ Dullness beyond the apical point of maximal impulse is seen in [[pericardial effusion]]<br>
::❑ Dullness beyond the apical point of maximal impulse is seen in [[pericardial effusion]]<br>
❑ Respiratory system: <br>
❑ Respiratory system: <br>  
:❑ [[Wheeze]] or [[rhales]]<br>
:❑ [[Wheeze]] or [[rales]]<br>
:❑ [[Pleural effusion]]<br>
:❑ [[Pleural effusion]]<br>
❑ Abdominal examination
❑ Abdominal examination
:❑ Pulsatile [[hepatomegaly]] (in constrictive pericarditis)
:❑ Pulsatile [[hepatomegaly]] (in [[constrictive pericarditis]])
:❑ [[Ascites]]<br>
:❑ [[Ascites]]<br>
</div>}}
</div>}}
Line 137: Line 160:
----
----
❑ [[Pericarditis electrocardiogram|Typical findings in pericarditis]]
❑ [[Pericarditis electrocardiogram|Typical findings in pericarditis]]
:❑ Widespread upward concave ST-segment elevation  
:❑ ST segment elevation in leads I, II, aVL, aVF, and V3-V6
:❑ PR-segment depression
:❑ PR-segment depression
:❑ Low-voltage QRS complexes (in large [[pericardial effusion]] and [[constrictive pericarditis]])
[[Image:Acute-pericarditis.jpg|center|200px]]
[[Image:Acute-pericarditis.jpg|center|200px]]
<br>
* Above EKG shows ST elevation in leads I, II, V2, V3, V4, V5, and V6 depicting acute pericarditis<br>
❑ [[Electrical alternans]] (in cardiac tamponade)<br>
❑ [[Electrical alternans]] (in [[cardiac tamponade]])<br>
----
----
'''Order imaging (urgent):'''<br>
'''Order imaging (urgent):'''<br>
----
----
❑ [[Chest X-ray]] <br>
❑ [[Chest X-ray]] <br>
:❑ [[Cardiomegaly]] (pericardial effusion)
:❑ A flask-shaped, enlarged cardiac silhouette ([[pericardial effusion]] and [[cardiac tamponade]])
:❑ Clear lung fields
:❑ Clear lung fields
[[Image:Pericardial effusion_3.jpg|thumb|150px|left|Pericardial effusion]]
[[Image:Pericardial effusion_3.jpg|thumb|150px|left|Pericardial effusion]]
Line 152: Line 176:
❑ [[Echocardiography]] <br>
❑ [[Echocardiography]] <br>
:❑ [[Pericarditis echocardiography|Diagnostic]]
:❑ [[Pericarditis echocardiography|Diagnostic]]
:❑ [[Pericardial effusion]]
:❑ Presence of moderate and large [[pericardial effusion]]
::❑ Circumferential
:❑ Right atrial collapse
::❑ Loculated
:❑ Diastolic collapse of right ventricle and left atrium (specific for cardiac tamponade)
:::❑ Anteriorly
:❑ Valvular abnormalities and masses
:::❑ Posteriorly
:❑ Findings suggestive of [[cardiac tamponade]] on subcostal view:
::❑ Collapse of the [[right atrium]]
::❑ Collapse of the [[right ventricle]]
:❑ [[Ejection fraction]], valvular abnormalities
</div>}}
</div>}}
{{familytree  | | | | | | | | | | |!| | | | | | | | | }}
{{familytree  | | | | | | | | | | |!| | | | | | | | | }}
{{familytree  | | | | | | | | | | C01 | | | | | | | | | | | | | | C01=<div style="float: left; text-align: left; padding:1em;">'''Diagnosis of acute pericarditis:'''<br>
{{familytree  | | | | | | | | | | C01 | | | | | | | | | | | | | | C01=<div style="float: left; text-align: left; padding:1em;">'''Diagnosis of acute pericarditis:'''<br>
'''Atleast two of the following criteria:'''<br>
'''Atleast two of the following criteria:'''<br>
❑ Characteristic chest pain  <br>
❑ Characteristic [[chest pain]] <br>
❑ Pericardial friction rub <BR>
[[Pericardial friction rub]] <BR>
❑ Suggestive EKG changes <br>
❑ Suggestive EKG changes <br>
❑ New or worsening pericardial effusion  <br>
❑ New or worsening [[pericardial effusion]] <br>
  </div>}}
  </div>}}
{{familytree  | | | | | | | |,|-|-|^|-|-|.| | | | | | | }}
{{familytree  | | | | | | | |,|-|-|^|-|-|.| | | | | | | }}
{{familytree  | | | | | | | D01 | | | | D02 | | | | | | D01=Yes| D02=No or equivocal}}
{{familytree  | | | | | | | D01 | | | | D02 | | | | | | D01=Yes| D02=No or equivocal}}
{{familytree  | | | | | | | |!| | | |,|-|^|-|-|.| | | }}
{{familytree  | | | | | | | |!| | | |,|-|^|-|-|.| | | }}
{{familytree  | | | | | | | E01 | | E02 | | | E03 | | E01= ❑ [[Acute pericarditis]] <br> ❑ [[Myopericarditis]] <br> * Elevated cardiac enzymes  <br>* Myocardial dysfunction on echo | E02=Consider cardiac MRI (CMR) | E03=Consider alternative diagnosis}}
{{familytree  | | | | | | | E01 | | E02 | | | E03 | | E01= ❑ [[Acute pericarditis]] <br> ❑ [[Myopericarditis]] <br> * Elevated cardiac enzymes  <br>* Global or focal myocardial dysfunction on echo | E02=Consider cardiac MRI (CMR) | E03=Consider [[Pericarditis differential diagnosis|alternative diagnosis]] and treat accordingly}}
{{familytree  | | | | | | | |!| | | |!| | | | | | | | }}
{{familytree  | | | | | | | |!| | | |!| | | | | | | | }}
{{familytree  | | | | | | | |!| | | F01 | | | | | | | F01= Treat as acute pericarditis or myopericarditis if there is delayed enhancement on CMR}}
{{familytree  | | | | | | | |!| | | F01 | | | | | | | F01= Treat as acute pericarditis or myopericarditis if there is delayed enhancement on CMR}}
{{familytree  | | | | | | | |`|-|v|-|'| | | | | | | | }}
{{familytree  | | | | | | | |`|-|v|-|'| | | | | | | | }}
{{familytree  | | | | | | | | | G01 | | | | | | | | | G01=<div style="float: left; text-align: left; padding:1em;">'''High risk features'''<br>
{{familytree  | | | | | | | | | G01 | | | | | | | | | G01=<div style="float: left; text-align: left; padding:1em;">'''High risk features'''<br>
❑ Fever >38°C <br>
[[Fever]] >38°C <br>
❑ Leucocytosis <BR>
[[Leucocytosis]] <BR>
❑ Subacute presentation <BR>
❑ Subacute presentation <BR>
❑ Cardiac tamponade <br>
[[Cardiac tamponade]] <br>
❑ Large pericardial effusion  <br>
❑ Large [[pericardial effusion]] <br>
❑ Elevated troponins (myopericarditis) <BR>
❑ Elevated troponins ([[myopericarditis]]) <BR>
❑ Concurrent oral [[anticoagulation]]  <br>
❑ Concurrent oral [[anticoagulation]]  <br>
❑ Lack of response to [[aspirin]] or [[NSAIDs]] after at least 1 wk of therapy  <br>
❑ Lack of response to [[aspirin]] or [[NSAIDs]] after at least 1 wk of therapy  <br>
❑ Immunosuppressed state  <br>
[[Immunosuppression|Immunosuppressed state]] <br>
❑ Acute trauma  <br>
❑ Acute [[trauma]] <br>
❑ Relapsing pericarditis  <br>  
❑ Relapsing pericarditis  <br>
</div>}}
</div>}}
{{familytree  | | | | | | |,|-|-|^|-|-|.| | | | | | | }}
{{familytree  | | | | | | |,|-|-|^|-|-|-|-|.| | | | | }}
{{familytree  | | | | | | H01 | | | | H02 |-|-|.| | | | H01=Inpatient treatment| H02=Outpatient treatment}}
{{familytree  | | | | | | H01 | | | | | | H02 | | | | H01=Yes| H02=No}}
{{familytree  | | | | |,|-|^|-|.| | | | | | | |!| | | | }}
{{familytree  | | | | | | |!| | | | | | | |!| | | | | H01=Yes| H02=No}}
{{familytree  | | | | J01 | | J02 | | | | | | |!| | | | | J01= Stable| J02= Unstable}}
{{familytree  | | | | | | H01 | | | | | | H02 | | | | H01=Inpatient treatment| H02=Outpatient treatment}}
{{familytree  | | | | |,|-|^|-|.| | | |,|-|^|-|.| | | | | }}
{{familytree  | | | | J01 | | J02 | | J03 | | J04 | | | | J01= Stable| J02= Unstable| J03= No pre-existing [[coronary artery disease]] | J04=Pre-existing [[coronary artery disease]]}}
{{familytree  | | | | |!| | | |!| | | | | | | |!| | | | |}}
{{familytree  | | | | |!| | | |!| | | | | | | |!| | | | |}}
{{familytree  | | | | I02 | | I03 | | | | | | I01 | | | | | I02= Clinical testing for underlying etiology| I03=<div style="float: left; text-align: left; padding:1em;">'''High risk features'''<br>
{{familytree  | | | | I02 | | I03 | | I04 | | I01 | | | | | I02=❑ [[NSAID's]] or [[aspirin]]<br> ❑ [[Colchicine]] may be used in recurrent or refractory disease<br> ❑[[Pericarditis 1 resident survival guide#Management#Etiology Specific Management|Clinical testing for underlying etiology]]| I03=<div style="float: left; text-align: left; padding:1em;">'''High risk features'''<br>
❑ Immediately transfer the patient to ICU <BR>
❑ Immediately transfer the patient to ICU <BR>
❑ Telemetry monitoring and frequent vital checks <BR>
❑ Telemetry monitoring and frequent vital checks <BR>
❑ Call cardiology team immediately <br>
❑ Call cardiology team immediately <br>
❑ [[Cardiac tamponade resident survival guide|Cardiac tamponade management]]  <br>
❑ [[Cardiac tamponade resident survival guide|Management of cardiac tamponade management]]  <br>
❑ Make sure patient is oxygenating well <BR>
❑ Make sure patient is oxygenating well <BR>
</div>| I01=<div style="float: left; text-align: left; width:25em; padding:1em;">'''NSAID's'''<br>
❑ [[Pericarditis 1 resident survival guide#Management#Etiology Specific Management|Clinical testing for underlying etiology]] <BR>
❑ [[NSAID's]] or [[aspirin]]<br> ❑ [[Colchicine]]</div>| I01=<div style="float: left; text-align: left; padding:1em;">'''[[Aspirin]]'''<br>
----
----
❑ [[aspirin|High-dose aspirin]]: <br>
❑ [[aspirin|High-dose aspirin]]: <br>
:❑ Orally 800 mg QID or TDS x 7-10 days <BR>
:❑ Orally 800 mg QID or TDS x 7-10 days <BR>
:❑ Gradual tapering by 800 mg/week for 3 additional weeks <br>
:❑ Gradual tapering by 800 mg/week for 3 additional weeks <br>
❑ Add gastroprotective agents  <br>
:❑ [[Misoprostol]] (600 to 800 mg/day)<BR>
:❑ [[Omeprazole]] (20 mg/day)  <br>
❑ Stop anticoagulants if patient develops [[pericardial effusion]]  <br>
----
'''Steroids'''<br>
----
❑ Avoid steroids to treat an initial episode of pericarditis  <br>
</div>| I04=<div style="float: left; text-align: left; padding:1em;">'''NSAID's'''<br>
----
❑ [[Indomethacin]]: <br>
❑ [[Indomethacin]]: <br>
:❑ Orally 50 mg TDS x 1-2 weeks<br>
:❑ Orally 50 mg TDS x 1-2 weeks<br>
:❑ Gradual tapering every 2-3 days for Rx period of 3-4 weeks<br>
:❑ Gradual tapering every 2-3 days for Rx period of 3-4 weeks<br>
:❑ Avoid in [[coronary artery disease]] patients<br>
:❑ Avoid in [[coronary artery disease]] patients<br>Or<br>
❑ [[Ibuprofen]]: <br>
❑ [[Ibuprofen]]: <br>
:❑ Orally 300-800 mg TDS or QID x 1-2 weeks<br>
:❑ Orally 300-800 mg TDS or QID x 1-2 weeks<br>
Line 228: Line 260:
❑ Avoid steroids to treat an initial episode of pericarditis  <br>
❑ Avoid steroids to treat an initial episode of pericarditis  <br>
</div>}}
</div>}}
{{familytree  | | | | | | | | | | | | | | |,|-|^|-|.| | | }}
{{familytree  | | | | | | | | | | | | |`|-|v|-|'| | | }}
{{familytree  | | | | | | | | | | | | | | J01 | | J02 | | J01= No relapse | J02= Relapse}}
{{familytree  | | | | | | | | | | | | | | J01 | | | J01=Response to Rx}}
{{familytree  | | | | | | | | | | | | | | |!| | | |!| | |}}
{{familytree  | | | | | | | | | | | | |,|-|^|-|.| | | }}
{{familytree  | | | | | | | | | | | | | | K01 | | K02 | | K01=<div style="float: left; text-align: left; padding:1em;">'''Follow up'''<br>
{{familytree  | | | | | | | | | | | | J01 | | J02 | | J01= Yes | J02= No}}
{{familytree  | | | | | | | | | | | | |!| | | |!| | |}}
{{familytree  | | | | | | | | | | | | K01 | | K02 | | K01=<div style="float: left; text-align: left; padding:1em;">'''Follow up'''<br>
❑ 7 to 10 days to assess response to treatment  <br>
❑ 7 to 10 days to assess response to treatment  <br>
❑ At 1 month check blood tests and CRP <BR>
❑ At 1 month check blood tests and CRP <BR>
❑ Thereafter only if symptoms recur <br>
❑ Thereafter only if symptoms recur <br>
  </div>| K02= Look below for management of relapsing pericarditis}}
  </div>| K02= <div style="float: left; text-align: left; padding:1em;">'''Hospital admission'''<br>
❑ Indication that the underlying cause may not be viral or idiopathic in nature.  <br>
❑ Inpatient therapy <BR>
❑ [[Pericarditis 1 resident survival guide#Management#Etiology Specific Management|Etiology specific management]] <br>
</div>}}
{{familytree  | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree  | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree/end}}
{{familytree/end}}
Line 241: Line 279:
===Etiology Specific Management===
===Etiology Specific Management===


{|class="wikitable"
{|class="wikitable"
! Clinical subgroups!! Specific investigations!! Treatment
! Clinical subgroups!! Specific investigations!! Treatment
|-
|-
| Viral pericarditis|| * Evaluation of pericardial effusion and/or pericardial/epicardial tissue <br> * PCR or in-situ hybridisation || * CMV pericarditis: Hyperimmunoglobulin OD 4 ml/kg on day 0, 4,and 8; 2 ml/kg on day 12 and 16.<br>* Coxsackie B pericarditis: Interferon alpha or beta 2,5 Mio. IU/m2 surface area s.c. 3 x per week<br> * Adenovirus and parvovirus B19 perimyocarditis: Immunoglobulin 10 g IV at day 1 and 3 for 6-8 hours
| Viral pericarditis|| ❑ Diagnostic [[pericardiocentesis]] <br> :❑ PCR or in-situ hybridisation || ❑ [[CMV]] pericarditis <br> :Hyperimmunoglobulin OD 4 ml/kg on day 0, 4,and 8; 2 ml/kg on day 12 and 16.<br>❑ [[Coxsackie B]] pericarditis<br> :Interferon alpha or beta 2,5 Mio. IU/m2 surface area s.c. 3 x per week<br> ❑ [[Adenovirus]] and [[parvovirus B19]] perimyocarditis <br> :Immunoglobulin 10 g IV at day 1 and 3 for 6-8 hours
|-
| Bacterial pericarditis|| ❑ Diagnostic [[pericardiocentesis]]<br> :❑ [[Gram stain]], acid fast stain, fungal stain, and cultures of the pericardial fluid <br> :❑ Protein, glucose and cell count <br> ❑ Gram stain, acid fast stain, fungal stain, and cultures of other body fluids ||❑ Therapeutic [[pericardiocentesis]] or [[pericardial window]]<br> ❑ [[Pericardiectomy]] may be used in treatment of recurrent pericardial efussion  and in patients with dense adhesions, loculated and thick purulent effusion<br> ❑ [[Pericarditis treatment#Management of Complicated Pericarditis|Antimicrobial therapy]] <br> :❑ Intiate antistaphylococcal antibiotic plus [[aminoglycoside]], followed by tailored antibiotic therapy according to pericardial fluid and blood cultures<br> :❑ Empiric regimen can be started for the following <br> ::❑ [[Immunosuppression]]<br> ::❑ Concurrent infection at another body site<br> ::❑ Presence of intravascular lines or prosthetic devices <br> ::❑ Recent antimicrobial therapy <br> ❑ [[Pericarditis treatment#Management of Complicated Pericarditis|Antifungal therapy]]
|-
| [[Tuberculous pericarditis]]||❑ [[CT scan]] and/or [[MRI]] of the chest <br> ❑ Culture of sputum, gastric aspirate, and/or urine <br> ❑ Diagnostic [[pericardiocentesis]] in all suspected tuberculous pericarditis patients <br> :❑ [[PCR]] of pericardial fluid<br>:❑ High [[adenosine deaminase]] activity and interferon gamma concentration in [[pericardial effusion]] <br> ❑ Pericardial biopsy (rapid diagnosis) <br> ❑ [[Tuberculin skin test]] (not helpful) <br> ❑ Enzyme-linked immunospot (ELISPOT)<br> ❑ Serum titres of antimyolemmal and antimyosin antibodies||❑[[Tuberculous pericarditis medical therapy|Anti-tuberculosis chemotherapy]]<br> :❑ Emperic therapy in TB endemic areas and in cases with high clinical suspicion<br> ❑ [[Pericardiectomy]] is warranted in the setting of persistent [[constrictive pericarditis]] or when no general improvement after 4-8 weeks following antituberculosis chemotherapy<br> ❑ [[Tuberculous pericarditis medical therapy#Role of Corticosteroids in Tuberculous pericarditis|Prednisone]] can be used.
|-
|-
| Bacterial pericarditis|| * Gram, acid-fast staining and cultures of the pericardial and body fluids ||* Rinsing of the pericardial cavity, combined with antistaphylococcal antibiotic plus aminoglycoside, followed by tailored antibiotic therapy according to pericardial fluid and blood cultures.<br>* Pericardiectomy is required in patients with dense adhesions, loculated and thick purulent effusion, recurrence of tamponade, persistent infection, and progression to constriction.<br>
| Neoplastic pericarditis ||❑ [[CT scan]] and/or [[MRI]] of the chest <br>  ❑ Diagnostic [[pericardiocentesis]] <br>  ❑ Pericardial biopsy || ❑ Systemic antineoplastic treatment <br> ❑ Assess the life expectancy of the patients before proceeding with the treatment<br> :❑ Better prognosis patients should be treated more aggressively <br> :❑ Advanced [[malignancy]] should be treated palliatively with [[pericardiocentesis]] <br> :❑ Recurrence of pericardial effusion is prevented using any of the following techniques <br> ::❑ Prolonged pericardiocentesis <br> ::❑ Pericardial sclerosis <br> ::❑ Pericardiotomy <br> ::❑ Intrapericardial chemotherapy
|-
|-
| Tuberculous pericarditis|| * PCR of pericardial fluid<br>* High adenosine deaminase activity and interferon gamma concentration in pericardial effusion<br>* Pericardial biopsy<br>* Tuberculin skin test<br>* Enzyme-linked immunospot (ELISPOT)<br>* Serum titres of antimyolemmal and antimyosin antibodies|| * Antituberculous therapy for 6, 9, 12 months.<br>* Pericardiectomy is warranted in the setting of persistent constrictive pericarditis.<br> * Prednisone 60 mg/day x 4 weeks, followed by 30 mg/day x 4 weeks, 15 mg/day x 2 weeks, and 5 mg/day x 1 week.
| Pericarditis in renal failure ||❑ Renal function test <br> ❑ Diagnostic [[pericardiocentesis]] <br> Pericardial biopsy || ❑ Uremic pericarditis <br> :❑ [[Hemodialysis]] or [[peritoneal dialysis]]<br> :❑ [[Heparin]]-free haemodialysis should be used <br> ❑ Dialysis-associated pericarditis <br> :❑ [[Pericardiocentesis]] for large effusion <br> :❑ Pericardiotomy in non resolving effusion<br>
|-
|-
|}
|}
==Do's==
==Do's==


Line 267: Line 308:


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 21:26, 12 March 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]

Overview

Acute pericarditis refers to inflammation of the pericardial sac, which can be dry, fibrinous or effusive, independent from its aetiology. The term myopericarditis, or perimyocarditis, is used for cases of acute pericarditis that also demonstrate myocardial inflammation resulting in global or regional myocardial dysfunction, elevations of troponins, MB creatine-kinase, myoglobin and tumour necrosis factor.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Management

The following is an algorithm depicting the management of acute pericarditis in adults.[1][2][3]

 
 
 
 
 
 
 
 
 
Characterize the Clinical, EKG and imaging findings

❑ Characteristic chest pain

❑ Sharp and pleuritic that is improved by sitting up and leaning forward

Pericardial friction rub

❑ High pitched, scratchy sound at the left sternal border best heard with diaphragm of the stethoscope
❑ Heard during atrial systole, ventricular systole and rapid ventricular filling during early diastole

❑ Suggestive EKG changes

❑ Diffuse ST elevation with reciprocal ST depression in leads aVR and V1

❑ Suggestive echocardiography changes

❑ New or worsening pericardial effusion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider a possible diagnosis of acute pericarditis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characterize the symptoms:

Symptoms suggestive of pericarditis:
Chest pain:

❑ Sudden onset
❑ Sharp or dull, aching and pressure like
❑ Pleuritic (exacerbated by inspiration and coughing)
❑ Retrosternal or radiation to neck, arms, trapezius muscle ridges
❑ Affected by position (improved by sitting up and leaning forward)
❑ No pain (uremia and tuberculosis pericarditis develop slowly)

Symptoms associated with pericardial effusion:
❑ Without a hemodynamically significant pericardial effusion

❑ No specific symptoms

❑ With a hemodynamically significant pericardial effusion

Fatigue
Breathlessness
Orthopnea
Dizziness
Loss of consciousness
Cool extremities
Peripheral cyanosis
Peripheral edema

Other associated symptoms:
Fever
Cough
Palpitations
Malaise
Joint pains
Odynophagia
Weight loss


Obtain a detailed history:
❑ Infections:

Pneumonia
Tuberculosis
HIV
❑ Travel history
❑ Travel to Central or South America (Chagas disease)
❑ Travel to Central Asia or South Africa (Tuberculosis)
❑ Travel to North and Central America (Ohio and Mississippi River valleys) (Histoplasmosis)
❑ Travel to North America (Blastomycosis)

Medications

❑ Systemic illness

Collagen vascular disease
Hypothyroidism
Inflammatory bowel disease
Malignancy
Uremia

❑ Others

Cardiac surgery
Radiation exposure
Dressler's syndrome
Postpericardiotomy syndrome
❑ Trauma history
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:

❑ Vitals

Pulse
Tachycardia (usual)
Bradycardia (in hypothyroidism and uremia)
Pulsus paradoxus (in cardiac tamponade)
Blood pressure
❑ Normal (usual)
Hypotension (in cardiac tamponade)
Temperature
Fever less than 39°C or 102.2°F
Hypothermic (in elderly and renal failure)
Respiratory rate
Tachypnea

❑ Cardiovascular:

❑ Heart sounds
❑ Normal (usual)
❑ Distant and muffled (in cardiac tamponade)
Pericardial friction rub
❑ High pitched, scratchy or squeaky sound
❑ Best heard at the left sternal border
❑ Best heard with the diaphragm of the stethoscope
❑ Vary in intensity overtime and need reapeated examinations

{{#ev:youtube|watch?v=EUCp_3_vwtw}}

Jugular venous pulse
❑ Elevated (in cardiac tamponade and constrictive pericarditis)
Kussmaul sign (in constrictive pericarditis)
❑ Any murmur
❑ Percuss cardiac dullness
❑ Dullness beyond the apical point of maximal impulse is seen in pericardial effusion

❑ Respiratory system:

Wheeze or rales
Pleural effusion

❑ Abdominal examination

❑ Pulsatile hepatomegaly (in constrictive pericarditis)
Ascites
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Order laboratory tests (urgent):

CBC: Leucocytosis
ESR: Elevated
C reactive protein: Elevated
Serum cardiac troponin I and T
Creatine kinase: CK-MB
Serum urea and creatinine


Order electrocardiogram (urgent):


Typical findings in pericarditis

❑ ST segment elevation in leads I, II, aVL, aVF, and V3-V6
❑ PR-segment depression
❑ Low-voltage QRS complexes (in large pericardial effusion and constrictive pericarditis)
  • Above EKG shows ST elevation in leads I, II, V2, V3, V4, V5, and V6 depicting acute pericarditis

Electrical alternans (in cardiac tamponade)


Order imaging (urgent):


Chest X-ray

❑ A flask-shaped, enlarged cardiac silhouette (pericardial effusion and cardiac tamponade)
❑ Clear lung fields
Pericardial effusion


Echocardiography

Diagnostic
❑ Presence of moderate and large pericardial effusion
❑ Right atrial collapse
❑ Diastolic collapse of right ventricle and left atrium (specific for cardiac tamponade)
❑ Valvular abnormalities and masses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagnosis of acute pericarditis:

Atleast two of the following criteria:
❑ Characteristic chest pain
Pericardial friction rub
❑ Suggestive EKG changes
❑ New or worsening pericardial effusion

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
No or equivocal
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acute pericarditis
Myopericarditis
* Elevated cardiac enzymes
* Global or focal myocardial dysfunction on echo
 
Consider cardiac MRI (CMR)
 
 
Consider alternative diagnosis and treat accordingly
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treat as acute pericarditis or myopericarditis if there is delayed enhancement on CMR
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
High risk features

Fever >38°C
Leucocytosis
❑ Subacute presentation
Cardiac tamponade
❑ Large pericardial effusion
❑ Elevated troponins (myopericarditis)
❑ Concurrent oral anticoagulation
❑ Lack of response to aspirin or NSAIDs after at least 1 wk of therapy
Immunosuppressed state
❑ Acute trauma
❑ Relapsing pericarditis

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inpatient treatment
 
 
 
 
 
Outpatient treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stable
 
Unstable
 
No pre-existing coronary artery disease
 
Pre-existing coronary artery disease
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NSAID's or aspirin
Colchicine may be used in recurrent or refractory disease
Clinical testing for underlying etiology
 
High risk features

❑ Immediately transfer the patient to ICU
❑ Telemetry monitoring and frequent vital checks
❑ Call cardiology team immediately
Management of cardiac tamponade management
❑ Make sure patient is oxygenating well
Clinical testing for underlying etiology

NSAID's or aspirin
Colchicine
 
NSAID's

Indomethacin:

❑ Orally 50 mg TDS x 1-2 weeks
❑ Gradual tapering every 2-3 days for Rx period of 3-4 weeks
❑ Avoid in coronary artery disease patients
Or

Ibuprofen:

❑ Orally 300-800 mg TDS or QID x 1-2 weeks
❑ Gradual tapering every 2-3 days
❑ Avoid in coronary artery disease patients

❑ Add gastroprotective agents

Misoprostol (600 to 800 mg/day)
Omeprazole (20 mg/day)

Colchicine


❑ Alone or in combination with NSAIDs
❑ Orally 0.5 mg BID x 3 months (>70 kg)
❑ Orally 0.5 mg OD x 3 months (≤70 kg)


Steroids


❑ Avoid steroids to treat an initial episode of pericarditis

 
Aspirin

High-dose aspirin:

❑ Orally 800 mg QID or TDS x 7-10 days
❑ Gradual tapering by 800 mg/week for 3 additional weeks

❑ Add gastroprotective agents

Misoprostol (600 to 800 mg/day)
Omeprazole (20 mg/day)

❑ Stop anticoagulants if patient develops pericardial effusion


Steroids


❑ Avoid steroids to treat an initial episode of pericarditis

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Response to Rx
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Follow up

❑ 7 to 10 days to assess response to treatment
❑ At 1 month check blood tests and CRP
❑ Thereafter only if symptoms recur

 
Hospital admission

❑ Indication that the underlying cause may not be viral or idiopathic in nature.
❑ Inpatient therapy
Etiology specific management

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Etiology Specific Management

Clinical subgroups Specific investigations Treatment
Viral pericarditis ❑ Diagnostic pericardiocentesis
 :❑ PCR or in-situ hybridisation
CMV pericarditis
 :❑ Hyperimmunoglobulin OD 4 ml/kg on day 0, 4,and 8; 2 ml/kg on day 12 and 16.
Coxsackie B pericarditis
 :❑ Interferon alpha or beta 2,5 Mio. IU/m2 surface area s.c. 3 x per week
Adenovirus and parvovirus B19 perimyocarditis
 :❑ Immunoglobulin 10 g IV at day 1 and 3 for 6-8 hours
Bacterial pericarditis ❑ Diagnostic pericardiocentesis
 :❑ Gram stain, acid fast stain, fungal stain, and cultures of the pericardial fluid
 :❑ Protein, glucose and cell count
❑ Gram stain, acid fast stain, fungal stain, and cultures of other body fluids
❑ Therapeutic pericardiocentesis or pericardial window
Pericardiectomy may be used in treatment of recurrent pericardial efussion and in patients with dense adhesions, loculated and thick purulent effusion
Antimicrobial therapy
 :❑ Intiate antistaphylococcal antibiotic plus aminoglycoside, followed by tailored antibiotic therapy according to pericardial fluid and blood cultures
 :❑ Empiric regimen can be started for the following
 ::❑ Immunosuppression
 ::❑ Concurrent infection at another body site
 ::❑ Presence of intravascular lines or prosthetic devices
 ::❑ Recent antimicrobial therapy
Antifungal therapy
Tuberculous pericarditis CT scan and/or MRI of the chest
❑ Culture of sputum, gastric aspirate, and/or urine
❑ Diagnostic pericardiocentesis in all suspected tuberculous pericarditis patients
 :❑ PCR of pericardial fluid
:❑ High adenosine deaminase activity and interferon gamma concentration in pericardial effusion
❑ Pericardial biopsy (rapid diagnosis)
Tuberculin skin test (not helpful)
❑ Enzyme-linked immunospot (ELISPOT)
❑ Serum titres of antimyolemmal and antimyosin antibodies
Anti-tuberculosis chemotherapy
 :❑ Emperic therapy in TB endemic areas and in cases with high clinical suspicion
Pericardiectomy is warranted in the setting of persistent constrictive pericarditis or when no general improvement after 4-8 weeks following antituberculosis chemotherapy
Prednisone can be used.
Neoplastic pericarditis CT scan and/or MRI of the chest
❑ Diagnostic pericardiocentesis
❑ Pericardial biopsy
❑ Systemic antineoplastic treatment
❑ Assess the life expectancy of the patients before proceeding with the treatment
 :❑ Better prognosis patients should be treated more aggressively
 :❑ Advanced malignancy should be treated palliatively with pericardiocentesis
 :❑ Recurrence of pericardial effusion is prevented using any of the following techniques
 ::❑ Prolonged pericardiocentesis
 ::❑ Pericardial sclerosis
 ::❑ Pericardiotomy
 ::❑ Intrapericardial chemotherapy
Pericarditis in renal failure ❑ Renal function test
❑ Diagnostic pericardiocentesis
❑ Pericardial biopsy
❑ Uremic pericarditis
 :❑ Hemodialysis or peritoneal dialysis
 :❑ Heparin-free haemodialysis should be used
❑ Dialysis-associated pericarditis
 :❑ Pericardiocentesis for large effusion
 :❑ Pericardiotomy in non resolving effusion

Do's

Dont's

References

  1. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y; et al. (2004). "Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology". Eur Heart J. 25 (7): 587–610. doi:10.1016/j.ehj.2004.02.002. PMID 15120056.
  2. Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B; et al. (2013). "American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography". J Am Soc Echocardiogr. 26 (9): 965–1012.e15. doi:10.1016/j.echo.2013.06.023. PMID 23998693.
  3. Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y (2010). "Controversial issues in the management of pericardial diseases". Circulation. 121 (7): 916–28. doi:10.1161/CIRCULATIONAHA.108.844753. PMID 20177006.


Template:WikiDoc Sources Template:WikiDoc Sources